Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to help heart patients kick the habit and beat the blues

NCT ID NCT03413423

Disease control Sponsor: Hennepin Healthcare Research Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a program called BAT-CS that combines smoking cessation counseling with mood management for people who have had a heart attack (acute coronary syndrome). The goal is to help them quit smoking and reduce depression symptoms, which could lower their risk of dying from another heart event. The study involves 233 participants who receive counseling sessions in the hospital and by phone over 12 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Behavioral Activation Treatment for Cardiac Smokers (BAT-CS) - a counseling program combining smoking cessation and mood management
What this could lead to
If successful, this program could become a standard approach to help heart attack survivors quit smoking and improve their mental health, potentially reducing their risk of future heart problems.
What could go wrong
This is a relatively small study (233 participants) testing a behavioral intervention, so results may not apply to everyone. The program requires multiple counseling sessions, and some people may not find it helpful or may relapse to smoking.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

233 people

The number who actually took part.

Started

Jan 2018

Expected to finish

May 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * hospital inpatients with an ACS diagnosis documented in medical record within the past 30 days * smoked equal or greater than 1 cigarette per day before being hospitalized * age of 18-75 years * English fluency * willing to consider quitting smoking at discharge * has a telephone or is willing to use a study issued cell phone * willing to consent to all study procedures. Exclusion Criteria: * limited mental competency * presence of severe mental illness that would interfere with participation or suicidality * expected discharge to hospice or greater than 50% chance of 6 month mortality per risk calculator * currently attending counseling for depression or smoking cessation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute coronary syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute coronary syndrome Depression nicotine dependence Smoking Tobacco Use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute coronary syndrome Tobacco use

Contacts and locations

Locations

  • Hennepin County Medical Center

    Minneapolis, Minnesota, 55415, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.